"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Tellus Therapeutics wins Early Stage Company Shootout

An A-list group of investors and companies attended the 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) on November 13-14th at the Loews Hotel in Atlanta. The Forum is the Southeast’s only regional life sciences venture capital conference. As always, one of the most popular parts of the conference is the Early Stage Shootout.

read more

ILiAD Biotechnologies Secures Up to $20 million of Financing

ILiAD Biotechnologies, LLC (ILiAD), announced the initial closing of a Class C financing, which will provide ILiAD with up to $20 million of proceeds. The initial closing includes commitments to fund $12.8 million. These funds will enable the company to conduct a Phase 2b BPZE1 clinical study following the Phase 2a study currently in progress at the Vanderbilt Vaccine Research Program.

read more

SEBIO Recognizes Best Deals in Class with Awards

Each year SEBIO recognizes healthcare and life sciences organizations in the Southeastern US whose achievements are bringing the region into focus as a hub of medical and technological innovation. The 2018 Investor and Partnering Forum in Atlanta, the organization’s 20th annual, honored five very worthy companies from across the region for their accomplishments this year.

read more